Observational Study Evaluating the Seroprotection of HepB-alum Vaccine and HepB-CpG Vaccine in People With HIV

BACKGROUND: Hepatitis B virus (HBV) vaccine seroprotection rates with conventional aluminum adjuvanted recombinant HBV vaccines, Engerix-B (HepB-alum) vaccine, among people with HIV (PWH) are varied. Heplisav-B (HepB-CpG) vaccine, a novel adjuvanted recombinant HBV vaccine, has shown higher seroprot...

Descripción completa

Detalles Bibliográficos
Autores principales: Reilly-Evans, Brenna, Dudzik, Beatrix, Costlow, David J, Hartmann, Carlos, Khalsa, Ann M, Kassis, Christelle, Zmarlicka, Monika T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300634/
https://www.ncbi.nlm.nih.gov/pubmed/37389224
http://dx.doi.org/10.1093/ofid/ofad267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300634/
https://www.ncbi.nlm.nih.gov/pubmed/37389224
http://dx.doi.org/10.1093/ofid/ofad267

Ejemplares similares